✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹6,836 Cr.
P/E
27.42
About
Aarti Pharmalabs Limited, formerly Aarti Organics Limited, is a prominent Indian pharmaceutical and nutraceutical manufacturer with an international presence. Specializing in Active Pharmaceutical Ing… Read more
Aarti Pharmalabs Limited, formerly Aarti Organics Limited, is a prominent Indian pharmaceutica… Read more
Low
488
52W Range
High
837
  • Aarti Pharmalabs
  • Shilpa Medicare
  • Supriya Lifescience

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statementNew
Edit rows
Forensics

5 Yes

Positive for this company

2 Neutral

Neutral for this company

8 No

Negative for this company

2 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Customer Segment

Peer Comparison
Corporate Actions
Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less
FAQs on Aarti Pharmalabs Ltd. Business

Aarti Pharmalabs Limited is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals, focusing on Active Pharmaceutical Ingredients and xanthine derivatives, leveraging process chemistry expertise and scale-up engineering.

Aarti Pharmalabs major competitors are Shilpa Medicare, Supriya Lifescience, AMI Organics, Aarti Drugs, Morepen Laboratories, Solara Active Pharma, IOL Chem & Pharma.
Market Cap of Aarti Pharmalabs is ₹6,679 Crs.
While the median market cap of its peers are ₹3,331 Crs.

Aarti Pharmalabs seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing
2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation Mar Jun Sep Dec Mar Jun Sep Dec
Conference Call Mar Jun Sep Dec Jun Sep Dec
Conference Call SummaryCon Call Summary
Discussions & Analysis
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material